A latent variable approach for modeling categorical endpoints among patients with rheumatoid arthritis treated with golimumab plus methotrexate

Author： Hu Chuanpu   Xu Zhenhua   Rahman Mahboob   Davis Hugh   Zhou Honghui  

Publisher： Springer Publishing Company

ISSN： 1567-567X

Source： Journal of Pharmacokinetics and Pharmacodynamics, Vol.37, Iss.4, 2010-08, pp. : 309-321

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Etanercept plus methotrexate is associated with improved clinical outcomes in patients with rheumatoid arthritis (RA) regardless of disease duration

By  

Inpharma, Vol. 1, Iss. 1615, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Exploratory analysis of four polymorphisms in human GGH and FPGS genes and their effect in methotrexate-treated rheumatoid arthritis patients

By van der Straaten RJHM   Wessels Judith AM   de Vries-Bouwstra Jeska K   Goekoop-Ruiterman Yvonne PM   Allaart Cornelia F   Bogaartz Judith   Tiller Marco   Huizinga Tom WJ   Guchelaar Henk-Jan  

Pharmacogenomics, Vol. 8, Iss. 2, 2007-02 ,pp. : 141-150

Future Medicine

Access to resources Recommend Favorite

Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate

By  

Arthritis & Rheumatism, Vol. 48, Iss. 10, 2003-10 ,pp. : 2763-2768

John Wiley & Sons Inc

Access to resources Recommend Favorite

GOlimumab GOes for GOld to treat rheumatoid arthritis

By  

Inpharma, Vol. 1, Iss. 1646, 2008-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Golimumab gets ready to go in rheumatoid arthritis

By  

Inpharma, Vol. 1, Iss. 1521, 2006-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite